Prognostic Scores Sample Clauses

Prognostic Scores. ^ The propensity score described in section 1.3 can be thought of as a summary of the associ- ation between treatment assignment and a collection of covariates. Similarly, the prognostic score can be thought of as a summary of the association between a potential outcome and a collection of covariates [Xxxxxx, 2008]. By conditioning on the regression of Yc on x (where Yc is the outcome under control and x is a vector of covariates), essentially identifying those covariates associated with outcome among the control group, one can achieve a type of balance like that obtained by conditioning on the propensity score. This idea has its roots in work by Xxxxxx [1941], Xxxxxx [1956], Xxxxxxx [1969], Xxxxx [1984], and Xxxxxxxxx and Greenhouse [1995] who all suggested “. . . estimating the treatment effect as the treatment group mean of yi − E(Yci|X = x) [Xxxxxx, 2008].” In other words, the observed outcome minus the predicted outcome based on parameters estimated from a regression model us- ing only the control patients. Xxxxxx [2008] defines these predictived outcome values as prognostic scores Ψ(X). Just as Xxxxxx compares achieving propensity balance to identifying the randomized ex- periment hidden in an observational study [2008], he likewise compares the application of prognostic scores to scientific experimentation: In a second experimental ideal, it is the process by which outcomes are gener- ated that is repeatable, understood, and carefully controlled, not the process of assigning units to treatment. Studies approaching this idea use experimental control in the interest of removing associations between covariates and potential outcomes, not treatment assignment. If in advance of studying a new experimen- tal manipulation, an investigator conducts tests absent the new manipulation in order to better understand accompanying conditions and their influence on the outcome, then it is this second ideal that her procedure seeks to attain. Xxxxxx states that “[p]rinciples of sufficiency and of conditional independence support a theory of prognostic balance that parallels Xxxxxxxxx and Xxxxx’x [1983a] account of propensity balance, with a few important differences [2008].” In general, if Yc⊥X|Ψ(X), XsA (1.10) for any measurable set A, then Ψ(X) is a prognostic score, and achieves ‘prognostic balance’ along the outcome measure for given X in the same sense that a propensity score achieves balance along the treatment assignment for given X. Unfortunately, this progn...
AutoNDA by SimpleDocs

Related to Prognostic Scores

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • Diagnostic Assessment 6.3.1 Boards shall provide a list of pre-approved assessment tools consistent with their Board improvement plan for student achievement and which is compliant with Ministry of Education PPM (PPM 155: Diagnostic Assessment in Support of Student Learning, date of issue January 7, 2013).

  • Diagnostic and Usage Data If you opt in to diagnostic and usage collection, you agree that Apple and its subsidiaries and agents may collect, maintain, process and use diagnostic, technical, usage and related information, including but not limited to information about your computer, system and application software, and peripherals, that is gathered periodically to facilitate the provision of software updates, product support and other services to you (if any) related to the Apple Software, and to verify compliance with the terms of this License. Apple may use this information, as long as it is collected in a form that does not personally identify you, to provide and improve Apple’s products and services. To enable Apple’s partners and third party developers to improve their software, hardware and services designed for use with Apple products, Apple may also provide any such partner or third party developer with a subset of diagnostic information that is relevant to that partner’s or developer’s software, hardware and/or services, as long as the diagnostic information is in a form that does not personally identify you.

  • Diagnostic Services Procedures ordered by a recognized Provider because of specific symptoms to diagnose a specific condition or disease. Some examples include, but are not limited to:

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Vaccinations Contractor understands, acknowledges, and agrees that, pursuant to Article II of the General Appropriations Act, none of the General Revenue Funds appropriated to the Department of State Health Services (DSHS) may be used for the purpose of promoting or advertising COVID-19 vaccinations in the 2024-25 biennium. It is also the intent of the legislature that to the extent allowed by federal law, any federal funds allocated to DSHS shall be expended for activities other than promoting or advertising COVID-19 vaccinations. Contractor represents and warrants that it is not ineligible, nor will it be ineligible during the term of this Contract, to receive appropriated funding pursuant to Article II.

  • Statistical Sampling Documentation a. A copy of the printout of the random numbers generated by the “Random Numbers” function of the statistical sampling software used by the IRO.

  • AUDIT OF LICENSED PRODUCT USAGE Contractor shall have the right to periodically audit, no more than annually, at Contractor’s expense, use of licensed Product at any site where a copy of the Product resides provided that: (i) Contractor gives Licensee(s) at least thirty (30) days advance written notice, (ii) such audit is conducted during such party’s normal business hours, (iii) the audit is conducted by an independent auditor chosen on mutual agreement of the parties. Contractor shall recommend a minimum of three (3) auditing/accounting firms from which the Licensee will select one (1). In no case shall the Business Software Alliance (BSA), Software Publishers Association (SPA), Software and Industry Information Association (SIIA) or Federation Against Software Theft (FAST) be used directly or indirectly to conduct audits, or be recommended by Contractor; (iv) Contractor and Licensee are each entitled to designate a representative who shall be entitled to participate, and who shall mutually agree on audit format, and simultaneously review all information obtained by the audit. Such representatives also shall be entitled to copies of all reports, data or information obtained from the audit; and (v) if the audit shows that such party is not in compliance, Licensee shall be required to purchase additional licenses or capacities necessary to bring it into compliance and shall pay for the unlicensed capacity at the NYS Net Price in effect at time of audit, or if none, then at the Contractor’s U.S. Commercial list price. Once such additional licenses or capacities are purchased, Licensee shall be deemed to have been in compliance retroactively, and Licensee shall have no further liability of any kind for the unauthorized use of the software.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

Time is Money Join Law Insider Premium to draft better contracts faster.